Leukotriene receptor
Leukotriene Receptor
The Leukotriene receptor is a type of protein that is found on the surface of cells in the human body. It is part of the G protein-coupled receptor family, which is a large group of proteins that play a crucial role in the body's response to various chemical signals.
Leukotriene receptors are primarily involved in the body's immune system response. They are activated by leukotrienes, which are a group of lipids produced by the body's white blood cells. When a leukotriene binds to its receptor, it triggers a series of events that lead to an inflammatory response.
There are two main types of leukotriene receptors: Cysteinyl leukotriene receptor 1 (CysLT1) and Cysteinyl leukotriene receptor 2 (CysLT2). These receptors are found in various tissues throughout the body, including the lungs, heart, and central nervous system.
CysLT1 is primarily involved in mediating the effects of leukotrienes in the lungs. It plays a key role in the development of asthma and allergic rhinitis, as it is involved in the constriction of bronchial tubes and the production of mucus.
CysLT2, on the other hand, is found in higher concentrations in the heart and central nervous system. It is involved in the regulation of cardiovascular and neurological functions.
The study of leukotriene receptors has led to the development of several pharmaceutical drugs, such as montelukast and zafirlukast, which are used to treat asthma and allergic rhinitis. These drugs work by blocking the action of leukotrienes at the CysLT1 receptor, thereby reducing inflammation and relieving symptoms.
Research into the function and potential therapeutic applications of leukotriene receptors is ongoing, with a particular focus on their role in inflammatory diseases and conditions such as atherosclerosis, stroke, and Alzheimer's disease.
This GPCR-related article is a stub. You can help WikiMD by expanding it.
This immune system related article is a stub. You can help WikiMD by expanding it.
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD